A hospitalização está associada a uma piora das condições de saúde bucal sendo assim, o cirurgião dentista no ambiente hospitalar atua na concretização do conceito de saúde integral e promoção da saúde. O objetivo deste estudo é conhecer o perfil epidemiológico bucal dos pacientes internados no Núcleo de Hospital Universitário Maria Aparecida Pedrossian da Universidade Federal do Mato Grosso do Sul (NHU-UFMS). Esta pesquisa foi desenvolvida de forma retrospectiva e aborda uma minuciosa e detalhada análise das informações dispostas no prontuário clínico. Foram incluídos no estudo os pacientes internados no período de março de 2012 a maio de 2013. A amostra envolveu um total de 188 pacientes, com idade média de 55,19 anos. As principais alterações extrabucais evidenciadas foram: assimetria de face (10,11%), linfadenopatia (5,32%), lábios desidratados ou descamativos (38,83%), lesão ulcerada em lábios (15,43%) e queilite angular (12,77%). Dentre as alterações intrabucais identificou-se principalmente: redução no fluxo salivar (27,13%), língua despapilada (17,55%), lesões de origem traumática na mucosa bucal (16,49%), candidíase (20,21%) e estomatite protética (6,38%). Dentre os pacientes dentados foi relatado: gengivite (77,24%), cálculo dental (46,90%), mobilidade dental (21,38%), cárie dental (55,86%), raiz residual (42,07%) e necessidade de exodontia (51,72%). Quanto à higiene bucal 30,32% da amostra apresentou uma condição satisfatória, 47,34% deficiente e 22,34% classificados com higiene bucal precária. Através deste estudo fica evidente a importância do cirurgião dentista em âmbito hospitalar, seja no tratamento de sequelas ou na prevenção dos fatores complicadores relacionados com a cavidade bucal durante o período da hospitalização.Descritores: Equipe Hospitalar de Odontologia; Higiene Bucal; Saúde Bucal; Manifestações Bucais.

No abstract

O fibroma ossificante periférico é uma patologia comum dos maxilares ocorrendo sobretudo pelo acúmulo de restos alimentares e traumatismos à gengiva e rebordo alveolar. Apresenta-se geralmente como um nódulo de limites definidos e de coloração semelhante a mucosa adjacente sendo normalmente assintomático, a depender do tamanho do mesmo. O objetivo deste artigo é apresentar um caso de paciente com 49 anos de idade com espectro autista, de comportamento difícil e nenhuma possibilidade de inter-relacionar-se com o cirurgião-dentista, com necessidade de exodontias múltiplas e remoção de fibroma ossificante periférico, em região de maxila a direita, de amplo tamanho. O paciente foi submetido aos procedimentos cirúrgicos em centro cirúrgico sob anestesia geral. Após remoção dos focos dentários e da lesão exofítica o paciente não apresentou recidiva da mesma.Descritores: Fibroma Ossificante; Diagnóstico; Terapêutica.ReferênciasFeller L, Buskin A, Raubenheimer EJ. Cemento-ossifying fibroma: case report and review of the literature. J Int Acad Periodontol. 2004;   6(4):131-35.Mishra MB, Bhishen KA, Mishra S. Peripheral ossifying fibroma. J Oral Maxillofac Pathol. 2011;15(1):65-8.García de Marcos JA, García de Marcos MJ, Arroyo Rodríguez S, Chiarri Rodrigo J, Poblet E. Peripheral ossifying fibroma: a clinical and immunohistochemical study of four cases. J Oral Sci. 2010;52(1):95-9.Kumar SK, Ram S, Jorgensen MG, Shuler CF, Sedghizadeh PP. Multicentric peripheral ossifying fibroma. J Oral Sci. 2006;48(4):239-43.Mugayar LRF. Pacientes portadores de necessidades especiais. Manual de Odontologia e Saúde Oral. Pancast: São Paulo; 2000.Andrade APP, Eleutéio ASL. Pacientes portadores de necessidades especiais: abordagem odontológica e anestesia geral. Rev bras odontol. 2015;72(1/2):66-9.Neville BW, Damm DD, Allen CM, Bouquot JE. Patologia Oral & Maxilofacial. 2 ed. Rio de Janeiro: Guanabara Koogan; 2004.Sabino NAR, Gaetti-Jardim EC, Gaetti-Jardim Jr E, de Melo RL. Arch Health Invest. 2016;5(4):214-16.Haddad AS. Odontologia para pacientes com necessidades especiais. São Paulo: Santos; 2007.

Paracoccidioidomycosis, a systemic fungal disease, can lead to dental disorders. As studies on dental problems in patients with paracoccidioidomycosis are few, we evaluated dental disorders and self-perceived oral health in this population.  The objective is to evaluate the oral condition of patients with paracoccidioidomycosis as well as their perception of the problem through a cross-sectional study of 52 adult patients with current or previous paracoccidioidomycosis in a reference hospital in Mato Grosso do Sul between December 2017 and July 2018. Demographic data, dental history, and self-perception of oral health were obtained from the National Oral Health Survey—SB Brazil 2010. The number of permanent decayed, missing, or filled teeth; presence and intensity of gingival bleeding; dental calculus; periodontal pockets; and periodontal attachment loss were recorded. Most patients had chronic paracoccidioidomycosis (n = 50; 96.2%), with involvement of the mouth in the active phase of the disease (n = 38; 73.1%). Participants had a high number of decayed, missing, or filled teeth (median: 30 teeth). The most compromised component was “missing” teeth (median of 21 teeth), and total edentulism was observed in 17 patients (32.7%). Periodontal disease was seen in 15 of 35 patients (43.3%) who had at least one tooth. Regarding satisfaction with their oral health, 27 patients (51.9%) reported being satisfied or very satisfied. There was no association between the degree of satisfaction with the other data. Tooth loss is the major dental problem in patients with paracoccidioidomycosis, and in patients with teeth, periodontal disease was highly prevalent. A general positive self-perception of oral health observed in these patients may reduce their willingness to seek dental treatment.

Objectives: Among the bone-targeted agents (BTAs) currently approved for the prevention of skeletal-related events (SREs), several characteristics may be considered by physicians when making treatment decisions. This study evaluated Canadian physicians' treatment preferences for BTAs used to prevent SREs in patients with bone metastases from solid tumors. MethOds: Physicians treating patients with bone metastases from solid tumors completed a web-enabled discrete-choice experiment survey consisting of 10 choices between pairs of hypothetical medication profiles for patient with either breast or prostate cancer. Each hypothetical medication profile included five attributes within a pre-defined range (primarily based on prescribing information): months until first SRE (10, 18 and 28 months); months until worsening of pain (3, 6 and 10 months); annual risk of osteonecrosis of the jaw (ONJ; 0%, 1% and 5%); annual risk of renal impairment (0%, 4% and 10%); and mode of administration (oral tablet, subcutaneous injection, 15-minute infusion and 120-minute infusion). Choice questions were based on an experimental design with known statistical properties. The survey was pretested with 8 physicians using open-ended interviews. A main-effects random parameters logit model was used to analyze the data. Results: A total of 200 Canadian physicians completed the survey. Over the attribute levels included, months until first SRE, the risk of renal impairment, and months until worsening of pain were the most important attributes. For those attributes, better levels (outcomes) were significantly preferred to worse levels (P < 0.05). For mode of administration, subcutaneous injection was preferred over infusion regardless of duration (P < 0.05). cOnclusiOns: When making treatment decisions regarding choice of BTA for patients with bone metastases, delaying the onset of SREs and managing the risk of renal impairment are the primary considerations for Canadian physicians. Also, respondents had well-defined preferences for subcutaneous injections over infusion every 4 weeks.